Question 1

What is LOPJLB’s current signal on SKYE?

Accepted Answer

LOPJLB’s latest quantitative signal on Skye Bioscience, Inc. (SKYE) is SELL in a CRISIS regime. Signals are updated daily.

Question 2

What market regime is SKYE in?

Accepted Answer

Skye Bioscience, Inc. (SKYE) is currently classified in the CRISIS HMM market regime on LOPJLB.

Question 3

What does Skye Bioscience, Inc. (SKYE) do?

Accepted Answer

Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on developing molecules that modulate G-protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1, a key GPCR involved in metabolic regulation. The company …

Question 4

Where is Skye Bioscience, Inc. based / listed?

Accepted Answer

Skye Bioscience, Inc. is based in US, listed on NASDAQ.

Skye Bioscience, Inc. (SKYE)

Key stats

Prediction markets

Company news